Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
The Journal of Pharmacology and Experimental Therapeutics|August 8, 1998
Pharmacology of [3H]prostaglandin E1/[3H]prostaglandin E2 and [3H]prostaglandin F2alpha binding to EP3 and FP prostaglandin receptor binding sites in bovine corpus luteum: characterization and correlation with functional dataN A Sharif, S X Xu, G W Williams, et al.
Cleveland Clinic Journal of Medicine|July 1, 1990
Clinical diagnoses and EEG interpretationG W Williams, R P Lesser, J B Silvers, et al.
The Physician and Sportsmedicine|July 28, 2016
Menstrual Abnormalities, Nutritional Patterns, and Body Composition in Female Classical Ballet DancersL H Calabrese, D T Kirkendall, M Floyd, et al.
The Journal of Biological Chemistry|August 15, 1989
Sequence requirements for apolipoprotein B RNA editing in transfected rat hepatoma cellsM S Davies, S C Wallis, D M Driscoll, et al.
JAMA|June 26, 1981
Selection of patients with chronic obstructive pulmonary disease for long-term oxygen therapyR M Timms, P A Kvale, N R Anthonisen, et al.
Controlled Clinical Trials|October 1, 1991
Design and statistical issues of the Modification of Diet in Renal Disease Trial. The Modification of Diet in Renal Disease Study GroupG J Beck, R L Berg, C H Coggins, et al.
The Journal of Thoracic and Cardiovascular Surgery|March 1, 1985
In vivo hemodynamic comparison of porcine and pericardial valvesD M Cosgrove, B W Lytle, C C Gill, et al.
Arthritis and Rheumatism|March 1, 1978
Therapeutic studies in NZB/NZW mice. VI. Age-dependent effects of concanavalin A stimulated spleen cell supernateA D Steinberg, R Krakauer, J L Reinertsen, et al.
Pharmaceutical Research|April 1, 1993
Comparison of the pharmacokinetics and pharmacodynamics of the aldose reductase inhibitors, AL03152 (RS), AL03802 (R), and AL03803 (S)Y H Park, P R Mayer, R Barker, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|December 17, 2008
Treatment of osteoarthritis with a once-daily dosing regimen of celecoxib: a randomized, controlled trialG W Williams, R E Ettlinger, E M Ruderman, et al.
Pageof 8